Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225565717> ?p ?o ?g. }
- W4225565717 abstract "Dopamine is used to treat patients with shock in intensive care units (ICU) throughout the world, despite recent evidence against its use. The aim of this study was to identify the latest practice of dopamine use in Japan and also to explore the consequences of dopamine use in a large Asian population.The Japanese Intensive Care PAtient Database (JIPAD), the largest intensive care database in Japan, was utilized. Inclusion criteria included: 1) age 18 years or older, 2) admitted to the ICU for reasons other than procedures, 3) ICU length of stay of 24 h or more, and 4) treatment with either dopamine or noradrenaline within 24 h of admission. The primary outcome was in-hospital mortality. Multivariable regression analysis was performed, followed by a propensity score-matched analysis.Of the 132,354 case records, 14,594 records from 56 facilities were included in this analysis. Dopamine was administered to 4,653 patients and noradrenaline to 11,844. There was no statistically significant difference in facility characteristics between frequent dopamine users (N = 28) and infrequent users (N = 28). Patients receiving dopamine had more cardiovascular diagnosis codes (70% vs. 42%; p < 0.01), more post-elective surgery status (60% vs. 31%), and lower APACHE III scores compared to patients given noradrenaline alone (70.7 vs. 83.0; p < 0.01). Multivariable analysis showed an odds ratio for in-hospital mortality of 0.86 [95% CI: 0.71-1.04] in the dopamine ≤ 5 μg/kg/min group, 1.46 [95% CI: 1.18-1.82] in the 5-15 μg/kg/min group, and 3.30 [95% CI: 1.19-9.19] in the > 15 μg/kg/min group. In a 1:1 propensity score matching for dopamine use as a vasopressor (570 pairs), both in-hospital mortality and ICU mortality were significantly higher in the dopamine group compared to no dopamine group (22.5% vs. 17.4%, p = 0.038; 13.3% vs. 8.8%, p = 0.018), as well as ICU length of stay (mean 9.3 days vs. 7.4 days, p = 0.004).Dopamine is still widely used in Japan. The results of this study suggest detrimental effects of dopamine use specifically at a high dose. Trial registration Retrospectively registered upon approval of the Institutional Review Board and the administration office of JIPAD." @default.
- W4225565717 created "2022-05-05" @default.
- W4225565717 creator A5001775532 @default.
- W4225565717 creator A5059191892 @default.
- W4225565717 creator A5072038504 @default.
- W4225565717 creator A5077111792 @default.
- W4225565717 creator A5090613385 @default.
- W4225565717 date "2022-04-02" @default.
- W4225565717 modified "2023-10-05" @default.
- W4225565717 title "Dopamine use and its consequences in the intensive care unit: a cohort study utilizing the Japanese Intensive care PAtient Database" @default.
- W4225565717 cites W1044268393 @default.
- W4225565717 cites W1630391490 @default.
- W4225565717 cites W1991490441 @default.
- W4225565717 cites W2000250316 @default.
- W4225565717 cites W2008746068 @default.
- W4225565717 cites W2011466577 @default.
- W4225565717 cites W2029411057 @default.
- W4225565717 cites W2029949452 @default.
- W4225565717 cites W2030294034 @default.
- W4225565717 cites W2031621601 @default.
- W4225565717 cites W2048437447 @default.
- W4225565717 cites W2054938569 @default.
- W4225565717 cites W2061926182 @default.
- W4225565717 cites W2067304703 @default.
- W4225565717 cites W2087423708 @default.
- W4225565717 cites W2089340253 @default.
- W4225565717 cites W2095944485 @default.
- W4225565717 cites W2107836934 @default.
- W4225565717 cites W2130459237 @default.
- W4225565717 cites W2150314311 @default.
- W4225565717 cites W2242506327 @default.
- W4225565717 cites W2315692219 @default.
- W4225565717 cites W2337580091 @default.
- W4225565717 cites W2345791523 @default.
- W4225565717 cites W2402683430 @default.
- W4225565717 cites W2409639413 @default.
- W4225565717 cites W2442492909 @default.
- W4225565717 cites W2461571468 @default.
- W4225565717 cites W2578725777 @default.
- W4225565717 cites W2612317261 @default.
- W4225565717 cites W2770453122 @default.
- W4225565717 cites W2800682399 @default.
- W4225565717 cites W2903491519 @default.
- W4225565717 cites W2920955762 @default.
- W4225565717 cites W2952316075 @default.
- W4225565717 cites W2967527181 @default.
- W4225565717 cites W2981815966 @default.
- W4225565717 cites W2999710113 @default.
- W4225565717 cites W3016555942 @default.
- W4225565717 cites W3105698797 @default.
- W4225565717 cites W3169519083 @default.
- W4225565717 cites W3193598686 @default.
- W4225565717 cites W4247448405 @default.
- W4225565717 doi "https://doi.org/10.1186/s13054-022-03960-y" @default.
- W4225565717 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35366934" @default.
- W4225565717 hasPublicationYear "2022" @default.
- W4225565717 type Work @default.
- W4225565717 citedByCount "2" @default.
- W4225565717 countsByYear W42255657172022 @default.
- W4225565717 countsByYear W42255657172023 @default.
- W4225565717 crossrefType "journal-article" @default.
- W4225565717 hasAuthorship W4225565717A5001775532 @default.
- W4225565717 hasAuthorship W4225565717A5059191892 @default.
- W4225565717 hasAuthorship W4225565717A5072038504 @default.
- W4225565717 hasAuthorship W4225565717A5077111792 @default.
- W4225565717 hasAuthorship W4225565717A5090613385 @default.
- W4225565717 hasBestOaLocation W42255657171 @default.
- W4225565717 hasConcept C126322002 @default.
- W4225565717 hasConcept C156957248 @default.
- W4225565717 hasConcept C177713679 @default.
- W4225565717 hasConcept C187212893 @default.
- W4225565717 hasConcept C194828623 @default.
- W4225565717 hasConcept C2776376669 @default.
- W4225565717 hasConcept C2987404301 @default.
- W4225565717 hasConcept C41008148 @default.
- W4225565717 hasConcept C513476851 @default.
- W4225565717 hasConcept C71924100 @default.
- W4225565717 hasConcept C77088390 @default.
- W4225565717 hasConceptScore W4225565717C126322002 @default.
- W4225565717 hasConceptScore W4225565717C156957248 @default.
- W4225565717 hasConceptScore W4225565717C177713679 @default.
- W4225565717 hasConceptScore W4225565717C187212893 @default.
- W4225565717 hasConceptScore W4225565717C194828623 @default.
- W4225565717 hasConceptScore W4225565717C2776376669 @default.
- W4225565717 hasConceptScore W4225565717C2987404301 @default.
- W4225565717 hasConceptScore W4225565717C41008148 @default.
- W4225565717 hasConceptScore W4225565717C513476851 @default.
- W4225565717 hasConceptScore W4225565717C71924100 @default.
- W4225565717 hasConceptScore W4225565717C77088390 @default.
- W4225565717 hasIssue "1" @default.
- W4225565717 hasLocation W42255657171 @default.
- W4225565717 hasLocation W42255657172 @default.
- W4225565717 hasLocation W42255657173 @default.
- W4225565717 hasLocation W42255657174 @default.
- W4225565717 hasOpenAccess W4225565717 @default.
- W4225565717 hasPrimaryLocation W42255657171 @default.
- W4225565717 hasRelatedWork W2008980667 @default.
- W4225565717 hasRelatedWork W2014790323 @default.
- W4225565717 hasRelatedWork W2026131789 @default.
- W4225565717 hasRelatedWork W2064711903 @default.